Hikma ramipril capsules recalled for failed impurity specification
Hikma Pharmaceuticals is recalling specific lots of Ramipril Capsules 10 mg because testing found higher-than-allowed levels of dicyclohexylurea, a process impurity. The affected lots are AC5470A and AC5470B, both expiring July 2027. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Hikma Pharmaceuticals recalls
What to do
- Check if your Ramipril prescription matches lot AC5470A or AC5470B with July 2027 expiration.
- Contact your pharmacy or doctor if you have one of these lots.
- Do not stop taking Ramipril without talking to your doctor first.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33432, Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- a) 25,970 bottles; b) 2,384 bottles
- Illnesses reported
- None reported
- Manufactured in
- 1809 Wilson Rd, N/A, Columbus, OH, United States
- Classification
- Class II
- Recall number
- D-0831-2026
In the FDA's words
- Description
- Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33432, Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228. Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU). a) Lot #: AC5470A, Exp. Date July 2027 b) Lot #: AC5470B, Exp. Date July 2027 Distribution: Nationwide within the United States Affected quantity: a) 25,970 bottles; b) 2,384 bottles
- Hazard
- Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
More from Hikma Pharmaceuticals
See all- Hikma ciprofloxacin 500 mg tablets recalled for N-nitroso impurity
ModerateFDANov 3, 2026
- Abirtega abiraterone tablets recalled for failed weight uniformity
ModerateFDAOct 23, 2026